Rheumatic heart disease and COVID-19
Eur Heart J
.
2020 Nov 7;41(42):4085-4086.
doi: 10.1093/eurheartj/ehaa660.
Authors
Andrea Beaton
1
,
Liesl Zühlke
2
3
,
Jeremiah Mwangi
4
,
Kathryn A Taubert
5
Affiliations
1
Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
2
Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
3
Department of Paediatric Cardiology, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.
4
Reach, Geneva, Switzerland.
5
Department of International Science and Health Strategies, American Heart Association International, Basel, Switzerland.
PMID:
33249463
PMCID:
PMC7799147
DOI:
10.1093/eurheartj/ehaa660
No abstract available
MeSH terms
COVID-19 / epidemiology
COVID-19 / etiology*
COVID-19 / prevention & control*
Global Health
Humans
Pandemics
Rheumatic Heart Disease / complications*
Rheumatic Heart Disease / therapy*
Risk Assessment
Risk Factors
Grants and funding
MR/S005242/1/MRC_/Medical Research Council/United Kingdom